(August 2020)

Are you worried that FAAMG stocks might see a correction which causes underperformance of your clients’ portfolios? Many are. With that in mind one idea is to look at financial funds, and particularly midcaps, to find some outperformance. Financials, like many other sectors, have lagged the performance of the handful of sectors that have thrived recently, but interestingly, there are some very good buys available. We mean there are many stocks with solid fundamentals, decent recovery pictures, and P/E ratios from 3x to 8x. One particularly good area is in midcap financials, where you encounter insurance companies, asset managers, and lenders that have strong underlying businesses, but are currently out of favor.

(New York)


FINSUM + Magnifi: There are a lot of good stocks to be had in this midcap financial area. Take Brighthouse (a spin-off from Metlife), for instance. The company has solid fundamentals and trades for 20% of book value right now (4x earnings)

Magnifi is changing the way we shop for investments, with the world’s first semantic search engine for finance that helps users discover, compare and buy investment products such as ETFs, mutual funds and stocks. Try it for yourself today.

This blog is sponsored by Magnifi. The information and data are as of the publish date unless otherwise noted and subject to change. This material is provided for informational purposes only and should not be construed as individualized investment advice or an offer or solicitation to buy or sell securities tailored to your needs. This information covers investment and market activity, industry or sector trends, or other broad-based economic or market conditions and should not be construed as investment research or advice. Investors are urged to consult with their financial advisors before buying or selling any securities. Although certain information has been obtained from sources believed to be reliable, we do not guarantee its accuracy, completeness or fairness. Past performance is no guarantee of future results. This content may not be reproduced or distributed to any person in whole or in part without the prior written consent of Magnifi. [As a technology company, Magnifi provides access to tools and will be compensated for providing such access. Magnifi does not provide broker-dealer, custodian, investment advice or related investment services.]